Real-time enrollment status for this tnbc - triple-negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:02 AM UTC
| NCT Number | NCT05491226 |
| Recruiting Status | Recruiting |
| Condition | TNBC - Triple-Negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 35 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Stephen Shiao |
| Last Updated on CT.gov | April 20, 2026 (Apr 20, 2026) |
As of July 13, 2026: Clinical trial NCT05491226 is currently recruiting participants. This clinical trial study for tnbc - triple-negative breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Stephen Shiao. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05491226 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05491226 was last updated Apr 20, 2026 (April 20, 2026). HelloStudys verifies this status automatically.